METTL3 and small cell lung carcinoma: Overexpressing METTL3 in SCLC cells significantly increased the IC50 of chemotherapy drugs, and deletion of the METTL3 methyltransferase domain blocked the chemotherapy resistance induced by METTL3 (Fig. 2L).